| Product Code: ETC13210353 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Breast Cancer Core Needle Biopsy Market was valued at USD 0.15 Billion in 2024 and is expected to reach USD 0.22 Billion by 2031, growing at a compound annual growth rate of 5.20% during the forecast period (2025-2031).
The Global Breast Cancer Core Needle Biopsy Market is experiencing steady growth driven by advancements in healthcare technology, rising prevalence of breast cancer, and increasing awareness about early detection. Core needle biopsy procedures offer higher accuracy in diagnosing breast cancer compared to traditional methods, driving their adoption worldwide. Key market players are focusing on developing innovative biopsy devices with enhanced precision and efficiency to meet the growing demand for minimally invasive diagnostic procedures. North America and Europe currently dominate the market due to well-established healthcare infrastructure and higher adoption rates of advanced medical technologies. However, the Asia-Pacific region is expected to witness significant growth opportunities in the coming years due to improving healthcare facilities and rising investments in cancer care. Overall, the Global Breast Cancer Core Needle Biopsy Market is poised for continued expansion in the foreseeable future.
The Global Breast Cancer Core Needle Biopsy Market is experiencing growth due to increasing awareness about early detection and advancements in imaging technologies. Key trends include the rising adoption of minimally invasive procedures, technological innovations in biopsy devices, and the development of personalized medicine approaches. Opportunities in the market lie in the growing demand for accurate and efficient diagnostic tools, particularly in emerging markets, as well as the expanding research and development activities aimed at improving biopsy techniques and outcomes. Additionally, collaborations between healthcare providers and biotechnology companies for the development of novel biopsy products and services are creating avenues for market expansion and differentiation. Overall, the market is poised for continued growth driven by the increasing prevalence of breast cancer and the focus on improving diagnostic accuracy and patient outcomes.
The Global Breast Cancer Core Needle Biopsy Market faces challenges such as limited access to advanced healthcare facilities in developing regions, which hinders the adoption of core needle biopsy procedures. Additionally, the high cost associated with core needle biopsy devices and procedures can act as a barrier for patients seeking diagnosis. Technical limitations in accurately identifying certain types of breast cancer through core needle biopsy, leading to potential misdiagnosis or inadequate sampling, also pose a challenge. Furthermore, the lack of standardized protocols and training for healthcare professionals performing core needle biopsies can impact the quality and consistency of results. Addressing these challenges will be crucial for the continued growth and effectiveness of core needle biopsy in diagnosing breast cancer globally.
The Global Breast Cancer Core Needle Biopsy Market is primarily driven by the increasing prevalence of breast cancer worldwide, leading to a growing demand for minimally invasive diagnostic procedures. The rising awareness about early detection and treatment of breast cancer, coupled with advancements in healthcare infrastructure and technologies, are also significant drivers of market growth. Additionally, the shift towards personalized medicine and targeted therapies in oncology is fueling the adoption of core needle biopsy techniques for accurate diagnosis and treatment planning. Moreover, the advantages offered by core needle biopsy, such as reduced procedure time, minimal scarring, and faster recovery compared to traditional surgical biopsies, are further driving the market expansion. Overall, the Global Breast Cancer Core Needle Biopsy Market is expected to continue growing due to these key drivers.
Government policies related to the Global Breast Cancer Core Needle Biopsy Market primarily focus on ensuring patient safety, promoting early detection, and improving quality of care. Regulations typically require healthcare facilities to adhere to specific guidelines for performing core needle biopsies to ensure accurate diagnosis and minimize risks. Government agencies also emphasize the importance of access to screening and diagnostic services for all populations, leading to initiatives to increase awareness and availability of core needle biopsy procedures. Additionally, funding and reimbursement policies play a crucial role in incentivizing healthcare providers to adopt advanced biopsy technologies and techniques. Overall, government policies aim to support advancements in breast cancer diagnosis and treatment through regulatory frameworks that prioritize patient outcomes and healthcare quality.
The Global Breast Cancer Core Needle Biopsy Market is expected to witness significant growth in the coming years due to factors such as increasing prevalence of breast cancer, advancements in biopsy technologies, and rising awareness about early detection of the disease. The market is projected to be driven by the growing demand for minimally invasive procedures, improved accuracy in diagnosis, and the shift towards personalized medicine. Additionally, the expanding healthcare infrastructure in developing economies, along with initiatives to improve access to screening and diagnostic services, will further propel market growth. However, challenges related to reimbursement policies, regulatory hurdles, and the high cost of biopsy procedures may hinder market growth to some extent. Overall, the Global Breast Cancer Core Needle Biopsy Market is anticipated to expand steadily in the forecast period.
In the global breast cancer core needle biopsy market, North America holds a significant share due to the well-established healthcare infrastructure, increasing prevalence of breast cancer, and higher adoption of advanced diagnostic technologies. Europe follows closely behind, driven by the growing awareness about early cancer detection and favorable reimbursement policies. Asia Pacific is poised for rapid growth with improving healthcare facilities, rising disposable income, and increasing initiatives for cancer screening programs. In the Middle East and Africa region, the market is steadily developing, supported by the rising focus on improving healthcare services and infrastructure. Latin America shows potential for market expansion due to increasing investments in healthcare and a growing emphasis on women`s health. Overall, the global breast cancer core needle biopsy market is witnessing growth opportunities across various regions, driven by advancements in diagnostic technologies and increasing focus on early cancer detection.
Global Breast Cancer Core Needle Biopsy Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Breast Cancer Core Needle Biopsy Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Breast Cancer Core Needle Biopsy Market Revenues & Volume, 2021 & 2031F |
3.3 Global Breast Cancer Core Needle Biopsy Market - Industry Life Cycle |
3.4 Global Breast Cancer Core Needle Biopsy Market - Porter's Five Forces |
3.5 Global Breast Cancer Core Needle Biopsy Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Breast Cancer Core Needle Biopsy Market Revenues & Volume Share, By Technology Scope, 2021 & 2031F |
3.7 Global Breast Cancer Core Needle Biopsy Market Revenues & Volume Share, By End-use Scope, 2021 & 2031F |
4 Global Breast Cancer Core Needle Biopsy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Breast Cancer Core Needle Biopsy Market Trends |
6 Global Breast Cancer Core Needle Biopsy Market, 2021 - 2031 |
6.1 Global Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By Technology Scope, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By MRI-Based Breast Biopsy, 2021 - 2031 |
6.1.3 Global Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By Ultrasound-Based Breast Biopsy, 2021 - 2031 |
6.1.4 Global Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By Mammography-Based (Stereotactic) Breast Biopsy, 2021 - 2031 |
6.1.5 Global Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By CT-Based Breast Biopsy, 2021 - 2031 |
6.1.6 Global Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By Other Image Based Breast Biopsy, 2021 - 2031 |
6.2 Global Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By End-use Scope, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By Biopharmaceutical Companies Hospitals & Diagnostic Laboratories, 2021 - 2031 |
6.2.3 Global Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By Pharmaceutical & Biotechnology companies, 2021 - 2031 |
6.2.4 Global Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By Academic & Research Institutes, 2021 - 2031 |
6.3.1 Overview & Analysis |
7 North America Breast Cancer Core Needle Biopsy Market, Overview & Analysis |
7.1 North America Breast Cancer Core Needle Biopsy Market Revenues & Volume, 2021 - 2031 |
7.2 North America Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Breast Cancer Core Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Breast Cancer Core Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Breast Cancer Core Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By Technology Scope, 2021 - 2031 |
7.4 North America Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By End-use Scope, 2021 - 2031 |
8 Latin America (LATAM) Breast Cancer Core Needle Biopsy Market, Overview & Analysis |
8.1 Latin America (LATAM) Breast Cancer Core Needle Biopsy Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Breast Cancer Core Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Breast Cancer Core Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Breast Cancer Core Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Breast Cancer Core Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By Technology Scope, 2021 - 2031 |
8.4 Latin America (LATAM) Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By End-use Scope, 2021 - 2031 |
9 Asia Breast Cancer Core Needle Biopsy Market, Overview & Analysis |
9.1 Asia Breast Cancer Core Needle Biopsy Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Breast Cancer Core Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Breast Cancer Core Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Breast Cancer Core Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Breast Cancer Core Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By Technology Scope, 2021 - 2031 |
9.4 Asia Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By End-use Scope, 2021 - 2031 |
10 Africa Breast Cancer Core Needle Biopsy Market, Overview & Analysis |
10.1 Africa Breast Cancer Core Needle Biopsy Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Breast Cancer Core Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Breast Cancer Core Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Breast Cancer Core Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Breast Cancer Core Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By Technology Scope, 2021 - 2031 |
10.4 Africa Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By End-use Scope, 2021 - 2031 |
11 Europe Breast Cancer Core Needle Biopsy Market, Overview & Analysis |
11.1 Europe Breast Cancer Core Needle Biopsy Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Breast Cancer Core Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Breast Cancer Core Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Breast Cancer Core Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Breast Cancer Core Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By Technology Scope, 2021 - 2031 |
11.4 Europe Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By End-use Scope, 2021 - 2031 |
12 Middle East Breast Cancer Core Needle Biopsy Market, Overview & Analysis |
12.1 Middle East Breast Cancer Core Needle Biopsy Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Breast Cancer Core Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Breast Cancer Core Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Breast Cancer Core Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By Technology Scope, 2021 - 2031 |
12.4 Middle East Breast Cancer Core Needle Biopsy Market, Revenues & Volume, By End-use Scope, 2021 - 2031 |
13 Global Breast Cancer Core Needle Biopsy Market Key Performance Indicators |
14 Global Breast Cancer Core Needle Biopsy Market - Export/Import By Countries Assessment |
15 Global Breast Cancer Core Needle Biopsy Market - Opportunity Assessment |
15.1 Global Breast Cancer Core Needle Biopsy Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Breast Cancer Core Needle Biopsy Market Opportunity Assessment, By Technology Scope, 2021 & 2031F |
15.3 Global Breast Cancer Core Needle Biopsy Market Opportunity Assessment, By End-use Scope, 2021 & 2031F |
16 Global Breast Cancer Core Needle Biopsy Market - Competitive Landscape |
16.1 Global Breast Cancer Core Needle Biopsy Market Revenue Share, By Companies, 2024 |
16.2 Global Breast Cancer Core Needle Biopsy Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |